Synthesis of nitrosourea derivatives of pyridine and piperidine as potential anticancer agents

Abstract
Nitrosourea derivatives 18-22 which utilize either a piperidine or pyridine ring as a carrier group were synthesized and evaluated for anticancer activity. N''-(1-Benzyl-4-piperidinyl)-N-(2-chloroethyl)-N-nitrosourea hydrogen maleate (19) exhibited good activity against intracranial [mouse] L1210 leukemia and the mouse ependymoblastoma brain tumor system. Compound 19 exhibited comparable activity in the [mouse] Lewis lung carcinoma system to N,N''-bis(2-chloroethyl)-N-nitrosourea. Replacement of the N-benzyl group in the 3-piperidinyl- and 4-piperidinylnitrosoureas resulted in less active compounds in all tumor systems tested. The 3-pyridylnitrosourea 22 was inactive in the L-1210 leukemia system.

This publication has 1 reference indexed in Scilit: